NCT05674383

Brief Summary

Rationale: For distal forearm fractures the investigators propose an anaesthetic method using an ultrasound guided axillary nerve block (ANB, an established technique) for pain reduction during reposition dislocated fractures. Nowadays a fracture hematoma block (FHB) is common practice, but is suboptimal due to variability between performing physicians and is often experienced as a painful procedure. The investigators want to investigate if ANB is an effective, safe and efficient option in pain reduction in patients of an ED (emergency department) population with a distal forearm fracture. Objective: To compare ultrasound-guided ANB with FHB for analgesia during reposition of non-operatively treated forearm fractures Study design: A randomized controlled trial. Study population: Patients ≥ 16 years of age with a closed, isolated and displaced distal forearm fracture requiring manipulative reposition. Intervention (if applicable): The intervention group will receive an ANB on the ipsilateral arm of the fracture. The control group will get a FHB. Main study parameters/endpoints: The primary outcome is pain score on a 11-point NRS (numeric rating scale) (0-10) during closed reposition of the dislocated distal forearm fracture in both groups. Main endpoint of this study is achieving a reduction of at least 2 points between both groups. This is considered as clinical relevant. Nature and extent of the burden and risks associated with participation, benefit and group relatedness: Patients participating in the research group are believed to have less pain and more comfort during reposition of the dislocated fracture. The investigators expect no other or more complications compared to standard care since the known complications are the same for both infiltrative anaesthetic interventions and are rare. Moreover, both procedures are common practice, therefore potential complications will be taken care of properly. The investigators expect there is no prolonged length of stay in the ED.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
117

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Jul 2021

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

July 1, 2021

Completed
1.5 years until next milestone

First Submitted

Initial submission to the registry

December 21, 2022

Completed
16 days until next milestone

First Posted

Study publicly available on registry

January 6, 2023

Completed
11 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 28, 2023

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

November 28, 2023

Completed
Last Updated

November 29, 2023

Status Verified

November 1, 2023

Enrollment Period

2.4 years

First QC Date

December 21, 2022

Last Update Submit

November 28, 2023

Conditions

Outcome Measures

Primary Outcomes (1)

  • Pain score

    The primary outcome is pain measured on a pain score using a 11-point NRS (0-10) during closed reposition of the dislocated distal forearm fracture in both groups

    15 minutes

Study Arms (2)

Intervention group

EXPERIMENTAL

The intervention group will receive an axillary plexus nerve block as pain reduction before the fracture repositioning.

Procedure: Axillary plexus nerve block

Control group

ACTIVE COMPARATOR

The control group will receive a fracture hematoma block as pain reduction before the fracture repositioning.

Procedure: Fracture hematoma block

Interventions

Axillary plexus nerve block: an ultrasound-guided axillary plexus nerve block with a single injection of lidocaine 1%.

Intervention group

Fracture hematoma block: a blinded single injection into the fracture with lidocaine 1%.

Control group

Eligibility Criteria

Age16 Years+
Sexall
Healthy VolunteersYes
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

  • Patients in the ED with a X-ray confirmed dislocated distal forearm fracture, defined as fracture \< 3cm within the radiocarpal joint with an abnormal anatomic position (dorsal angulation \>10°, volar angulation \>20°, radioulnar inclination \<15°, \>5mm radial collapse or intra-articular incongruence \>2mm.
  • ≥ 16 years of age
  • Patients who have adequate knowledge and understanding of the Dutch language

You may not qualify if:

  • 'Open' fractures requiring surgery
  • Multi-trauma patients
  • Abnormal neurovascular examination requiring immediate reposition or surgery
  • Pre-existent osteosynthesis material in situ on the present fracture site.
  • Skin injury, local infection or recent burns hindering the use of ultrasound.
  • Allergy for local anaesthetics
  • Inability to give informed consent (cognitive impairments, no good understanding of the Dutch or English language)
  • Severe coagulopathy (i.e. severe thrombocytopenia, haemophilia.). Usage of anticoagulation is not an contra-indication, since any bleeding complication has few adverse consequences(20).
  • High risk on compartment syndrome (in consultation with surgery department).

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Medisch centrum Leeuwarden

Leeuwarden, Provincie Friesland, 8934AD, Netherlands

Location

MeSH Terms

Conditions

Wrist Fractures

Condition Hierarchy (Ancestors)

Wrist InjuriesArm InjuriesWounds and InjuriesFractures, Bone

Study Officials

  • Heleen Lameijer, Dr

    Heleen.Lameijer1@mcl.nl

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: Randomized controlled trial
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Investigator

Study Record Dates

First Submitted

December 21, 2022

First Posted

January 6, 2023

Study Start

July 1, 2021

Primary Completion

November 28, 2023

Study Completion

November 28, 2023

Last Updated

November 29, 2023

Record last verified: 2023-11

Data Sharing

IPD Sharing
Will not share

Locations